The webinar was hosted by IAS – the International AIDS Society – on 4 April 2023, provided updates on innovations in the treatment and prevention of HIV and tuberculosis (TB) co-infections, including the World Health Organization’s (WHO’s) recently published module in its consolidated guidelines on TB: drug-resistant tuberculosis treatment 2022 update. Participants will hear from MedAccess about an agreement to reduce the price of a recently announced alternative drug to treat multidrug-resistant TB and what this means for the treatment of HIV and TB. Finally, civil society representatives will share their experiences on integrated community engagement interventions and new innovative models of treatment for HIV and TB.
HIV and TB co-infections: latest updates and innovations
Chairs
Speakers

Fuad Mirzayev
Team Lead, TB treatment team
Prevention, Diagnosis, Treatment, Care and Innovation Unit (PCI) WHO Global TB Programme (GTB)
Updated WHO consolidated guidelines on DR-TB treatment 2022
Hema Srinivasan
Chief Access Officer
MedAccess
Market shaping to improve equitable access to drug-resistant TB treatment
- Hema Srinivasan presentation slides.pdf (647.17 KB)

Ashna Ashesh
MDR TB Survivor, Public Health Professional, Lawyer, Member, rGLC, SEA, WHO; and Fellow, SATB
Integrated community engagement interventions in HIV-TB
- Ashna Ashesh presentation slides.pdf (79.69 KB)

Wame Jallow
Vice President of International Programs
Population Media Center
The ‘whole-society’ & innovative models to treating co-infections
- Wame Jallow presentation slides.pdf (1.12 MB)